In view of the global trend of an aging society, the significant increase in health care expenses has become a major economic and social challenge for many countries around the world, the current medical behavior is to see a doctor for treatment only after the onset of a disease, if the concept is changed in the subhealthy to the onset of the disease, or to manage the health status of the health status of the time so that health is effectively maintained, it will reshape the medical behavior from health care to the health management of the new chapter is expected to reduce the heavy burden of health care and reduce the cost of social care, and will lead to a new wave of industry prospects. It is expected to reduce the heavy burden of medical care and the cost of social care, as well as bring about a new wave of industrial profitability.

Precision medicine covers the areas of precision prevention, precision prediction, precision diagnosis and precision treatment from the medical side, while precision health focuses on precision prevention and precision prediction from the consumer health side, both of which are essential and closely related to the needs of human life. 2015 saw the introduction of Precision Medicine Initiatives (PMI) in the United States, following the Human Genome Project, to study the relationship between personal genes and healthcare benefits. With the approval of the first Luxturna gene therapy in 2017, in addition to establishing the medical application of gene therapy, it also symbolizes the opening of the era of personalized (genetic) medicine, which emphasizes the importance of health in the human life process, and the need for precise health at all ages is the only way to achieve human health and the future of medical development. The future of human health and medical development is to have accurate health for all ages, and then the All of Us Precision Health was born (U.S. All of Us Research Program), and the genetic analysis of millions of people and the health data tracking database were carried out. In this context, with the core of biomedical data such as genetic, physiological, psychological, and behavioral data, biomarkers, clinical application standards, or health monitoring indicators of value for medical applications (detection, screening, diagnosis, or treatment) can be identified through translational medicine, combined with ICT, big data, AI/ML, and 5G, and combined with other drugs/medicines/therapeutics, either individually or through software or digital devices, and then used as the basis for the development of a new drug/medicine/therapeutic. Precision medicine and precision health industry ecosystem is regarded as the international healthcare development epiphany, and is also the focus of international hot money investment in recent years.